CalEye.
Free tool · No signup

DASH Diet Calculator

Find your daily DASH diet servings scaled to your calorie target. Based on NHLBI 2006 guidelines + Sacks 2001 NEJM trial. Drops systolic BP 8–14 mmHg in hypertensive adults within 4 weeks — comparable to a single antihypertensive medication.

What DASH actually is

The Dietary Approaches to Stop Hypertension eating plan was developed in the 1990s by an NHLBI consortium specifically to lower blood pressure through diet alone. Unlike most named diets, DASH was designed and tested as a structured intervention — explicit serving counts per food group, controlled feeding studies, and dose-response evaluation. The Sacks 2001 DASH-Sodium trial in the New England Journal of Medicine demonstrated SBP reductions of 8–14 mmHg in hypertensive subjects within 4 weeks of adherence, a magnitude comparable to a single antihypertensive drug.

The structure: servings per food group

Per the NHLBI 2,000 kcal DASH template:

Sodium and potassium — the lever

The DASH eating pattern alone reduces SBP by ~4–6 mmHg. Adding sodium restriction (≤2,300 mg/day standard, ≤1,500 mg/day intensive) adds another 4–8 mmHg. The lower-sodium variant is harder to maintain because virtually all processed foods, restaurant meals, and many "healthy" packaged items are sodium-loaded — but the reward is the largest non-medication BP reduction available.

Potassium is the under-appreciated other half. DASH targets ≥4,700 mg/day, hit through generous fruit and vegetable intake. The 2013 Aburto BMJ meta-analysis showed boosting potassium from 2,400 to 3,500 mg/day reduced SBP by 7.2 mmHg in hypertensive subjects independently of sodium reduction. Together, sodium reduction + potassium increase produce most of the DASH benefit.

Why DASH works for diabetes too

Although designed for hypertension, DASH meaningfully improves multiple metabolic markers. The 2014 Hinderliter et al. systematic review showed DASH reduced fasting glucose by 5–10 mg/dL, lowered LDL cholesterol by 10–15 mg/dL, and reduced insulin resistance (HOMA-IR) by ~15% over 8–16 weeks. The mechanism overlaps with the Mediterranean diet: high fiber, high potassium, low glycemic load, anti-inflammatory food patterns. The 2017 Soltani et al. meta-analysis ranked DASH alongside Mediterranean as one of the two most evidence-supported diets for both CVD prevention and T2D management.

Related tools

Frequently asked questions

What is the DASH diet and where did it come from?
DASH stands for Dietary Approaches to Stop Hypertension. It was developed in the 1990s by an NHLBI-funded research consortium and validated by the DASH-Sodium trial (Sacks et al., NEJM 2001), which randomised 412 adults to either a standard American diet or DASH at three sodium levels. Results: full DASH reduced systolic blood pressure by 8–14 mmHg in hypertensive subjects within 4 weeks — a magnitude comparable to a single antihypertensive medication. The diet emphasises whole grains, fruits, vegetables, low-fat dairy, lean protein, nuts, and legumes, while limiting red meat, sugar, and sodium. It has been consistently ranked the #1 overall diet by US News & World Report since the rankings began in 2011.
How is DASH different from the Mediterranean diet?
DASH is the more clinically structured of the two — designed specifically for blood pressure reduction with explicit serving counts per food group. Mediterranean is broader, emphasising olive oil, fish, vegetables, legumes, whole grains, and moderate wine, drawn from traditional dietary patterns in Greece, Italy, and southern Spain. Mediterranean has the stronger evidence for cardiovascular event reduction (PREDIMED 2013 NEJM, 30% reduction in events) while DASH has the strongest evidence for BP reduction specifically. They overlap substantially — both restrict processed foods, emphasise plant foods, and avoid added sugar — and many clinicians recommend a hybrid pattern.
Does DASH actually work without medication?
For mild-to-moderate hypertension (Stage 1, 130–139/80–89), often yes. The Sacks 2001 DASH-Sodium trial showed 8–14 mmHg SBP reduction in hypertensive subjects with full adherence to DASH plus sodium <2,300 mg/day. Combined with weight loss (1 mmHg per kg lost), aerobic exercise (5–8 mmHg), and reduced alcohol (3–5 mmHg), many adults can normalise Stage 1 hypertension without drugs. Stage 2 hypertension (≥140/90) typically requires medication alongside lifestyle changes — but DASH still reduces the dose and number of meds needed.
What's the lower-sodium DASH version?
Standard DASH targets ≤2,300 mg/day sodium (about 1 teaspoon of salt). The lower-sodium DASH version targets ≤1,500 mg/day. Sacks 2001 found that reducing sodium from 3,500 to 1,500 mg/day produced an additional 4–5 mmHg SBP reduction on top of the food-pattern benefits. The 1,500 mg target is tough — most processed foods, restaurants, and even "healthy" packaged foods are sodium-loaded. Most adherent low-sodium DASH practitioners cook almost everything from scratch and read labels constantly.
Why does potassium matter so much for blood pressure?
Potassium directly counteracts sodium's blood pressure effect through the renin-angiotensin-aldosterone system. The 2013 Aburto meta-analysis (BMJ) of 33 RCTs showed increasing potassium intake from ~2,400 to ~3,500 mg/day reduced SBP by 7.2 mmHg in hypertensive subjects — magnitude comparable to a single antihypertensive. DASH targets ≥4,700 mg/day, hit through generous fruit and vegetable intake. Caveat: people on potassium-sparing diuretics, ACE inhibitors, or with kidney disease should consult their care team before aggressively increasing potassium — the same mechanism that lowers BP can cause hyperkalemia in those contexts.
Track it

Stop estimating. Start tracking.

CalEye reads calories, protein, carbs, and fat from a photo of your plate — no barcode, no manual entry. Free on iOS.

Download CalEye free on iOS →